DK164325B - Analogifremgangsmaade til fremstilling af terapeutisk aktive androstanderivater - Google Patents

Analogifremgangsmaade til fremstilling af terapeutisk aktive androstanderivater Download PDF

Info

Publication number
DK164325B
DK164325B DK327082A DK327082A DK164325B DK 164325 B DK164325 B DK 164325B DK 327082 A DK327082 A DK 327082A DK 327082 A DK327082 A DK 327082A DK 164325 B DK164325 B DK 164325B
Authority
DK
Denmark
Prior art keywords
hydroxy
methyl
androstan
androsten
general formula
Prior art date
Application number
DK327082A
Other languages
Danish (da)
English (en)
Other versions
DK327082A (da
Inventor
Dieter Bittler
Henry Laurent
Klaus Nickisch
Rudolf Wiechert
Manfred Albring
Annerose Schleusener
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of DK327082A publication Critical patent/DK327082A/da
Publication of DK164325B publication Critical patent/DK164325B/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/005—Ketals
    • C07J21/006—Ketals at position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0033—Androstane derivatives substituted in position 17 alfa and 17 beta
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002—Carbocyclic rings fused
    • C07J53/004—3 membered carbocyclic rings
    • C07J53/005—3 membered carbocyclic rings in position 12
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002—Carbocyclic rings fused
    • C07J53/004—3 membered carbocyclic rings
    • C07J53/008—3 membered carbocyclic rings in position 15/16
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK327082A 1981-07-29 1982-07-21 Analogifremgangsmaade til fremstilling af terapeutisk aktive androstanderivater DK164325B (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19813130644 DE3130644A1 (de) 1981-07-29 1981-07-29 Neue androstan-derivate, verfahren zu ihrer herstellung und pharmazeutische praeparate, die diese verbindungen enthalten
DE3130644 1981-07-29

Publications (2)

Publication Number Publication Date
DK327082A DK327082A (da) 1983-01-30
DK164325B true DK164325B (da) 1992-06-09

Family

ID=6138450

Family Applications (1)

Application Number Title Priority Date Filing Date
DK327082A DK164325B (da) 1981-07-29 1982-07-21 Analogifremgangsmaade til fremstilling af terapeutisk aktive androstanderivater

Country Status (17)

Country Link
US (2) US4457925A (pt)
EP (1) EP0071153B1 (pt)
JP (1) JPS5849400A (pt)
AT (1) ATE22086T1 (pt)
AU (1) AU558412B2 (pt)
CA (1) CA1210754A (pt)
DE (2) DE3130644A1 (pt)
DK (1) DK164325B (pt)
ES (1) ES514492A0 (pt)
FI (1) FI78110C (pt)
GB (1) GB2104899B (pt)
GR (1) GR76872B (pt)
IE (1) IE53711B1 (pt)
IL (1) IL66311A (pt)
NO (1) NO159661C (pt)
PT (1) PT75334B (pt)
ZA (1) ZA825480B (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3331824A1 (de) * 1983-09-01 1985-03-21 Schering AG, Berlin und Bergkamen, 1000 Berlin Verfahren zur herstellung von 17(alpha)-acyloxy-6-chlor-1(alpha),2(alpha)-methylen-3,20-dionen
DE3347126A1 (de) * 1983-12-22 1985-07-11 Schering AG, 1000 Berlin und 4709 Bergkamen 11ss-aryl-estradiene, deren herstellung und diese enthaltende pharmazeutische praeparate
US4720489A (en) * 1984-10-15 1988-01-19 Douglas Shander Hair growth modification with ornithine decarboxylase inhibitors
JPS61286185A (ja) * 1985-06-13 1986-12-16 Yoshizo Koishi 刻印装置
DE3824247A1 (de) * 1988-07-13 1990-01-18 Schering Ag Neue androstan-derivate
GB9021546D0 (en) * 1990-10-04 1990-11-21 Beecham Group Plc Novel composition
DE4102244A1 (de) * 1991-01-24 1992-07-30 Schering Ag 14,16ss-ethano-15ss, 16(pfeil hoch)1(pfeil hoch)-cyclo-14ss-estra-1,3,5(10)-triene
US6743419B1 (en) 1992-12-22 2004-06-01 The Gillette Company Method of reducing hair growth employing sulfhydryl active compounds
US5411991A (en) * 1992-12-22 1995-05-02 Shander; Douglas Method of reducing hair growth employing sulfhydryl active compounds
CA2522784C (en) * 2003-04-01 2012-06-19 Hollis-Eden Pharmaceuticals, Inc. Antiandrogens with marginal agonist activity and methods of use
US8084446B2 (en) * 2005-04-26 2011-12-27 Eric Marchewitz Use of DHEA derivatives for enhancing physical performance
US20130123523A1 (en) * 2011-11-10 2013-05-16 Klaus Nickisch Methods for the preparation of etonogestrel and desogestrel

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR7871M (pt) * 1968-11-13 1970-04-27
DE2644427A1 (de) * 1976-09-30 1978-04-06 Schering Ag 17 beta-hydroxy-17 alpha-(3-acyloxypropyl)-4.6-androstadien-3-one und deren salze
CH631462A5 (de) * 1976-03-05 1982-08-13 Schering Ag Verfahren zur herstellung von neuen steroiden der androstan- oder oestranreihe.
DE2722706A1 (de) * 1977-05-16 1978-12-07 Schering Ag 15.16-methylen-androsta-4.15-dien- 3-one und verfahren zu ihrer herstellung
ES469510A1 (es) * 1977-05-16 1978-12-01 Schering Ag Procedimiento para la preparacion de 17beta hidroxi-4-an- drosten-3-onas.

Also Published As

Publication number Publication date
IE821824L (en) 1983-01-29
JPS5849400A (ja) 1983-03-23
DE3273186D1 (en) 1986-10-16
DE3130644A1 (de) 1983-02-17
FI78110B (fi) 1989-02-28
US4457925A (en) 1984-07-03
GB2104899B (en) 1985-01-30
AU8643982A (en) 1984-10-18
PT75334A (de) 1982-08-01
NO159661C (no) 1989-01-25
EP0071153B1 (de) 1986-09-10
NO822596L (no) 1983-01-31
IL66311A (en) 1986-03-31
CA1210754A (en) 1986-09-02
EP0071153A1 (de) 1983-02-09
NO159661B (no) 1988-10-17
ATE22086T1 (de) 1986-09-15
ZA825480B (en) 1983-11-30
US4587235A (en) 1986-05-06
JPH033678B2 (pt) 1991-01-21
GR76872B (pt) 1984-09-04
ES8305003A1 (es) 1983-04-16
FI822658A0 (fi) 1982-07-29
ES514492A0 (es) 1983-04-16
IL66311A0 (en) 1982-11-30
FI822658L (fi) 1983-01-30
AU558412B2 (en) 1987-01-29
IE53711B1 (en) 1989-01-18
FI78110C (fi) 1989-06-12
PT75334B (de) 1984-07-31
DK327082A (da) 1983-01-30
GB2104899A (en) 1983-03-16

Similar Documents

Publication Publication Date Title
EP0422100B1 (en) 11 beta-substituted progesterone analogs
EP0188396B1 (fr) Nouveaux stéroides substitués en position 10, leur procédé et les intermédiaires de préparation, leur application comme médicaments, les compositions pharmaceutiques les contenant
EP0196707B1 (fr) Nouveaux 19-nor stéroides substitués en 11, en 17 et éventuellement en 2, leur préparation, leur application comme médicaments, les compositions les renfermant et les nouveaux intermédiaires obtenus
SU1715205A3 (ru) Способ получени стероидов, замещенных спирановым циклом
CH657368A5 (fr) Derives de 3-ceto delta-4,9 19-nor-steroides, leur preparation, les compositions les renfermant et les produits de depart pour leur preparation.
KR100511815B1 (ko) 플루오르화된 17α-알킬 사슬이 있는 항제스타겐성 스테로이드
DK164325B (da) Analogifremgangsmaade til fremstilling af terapeutisk aktive androstanderivater
CA1051868A (en) D-homo-20-keto-pregnanes
DK161708B (da) 11beta-aryloestradiener, deres anvendelse, fremgangsmaade til fremstilling heraf og farmaceutiske praeparater med indhold deraf
DK162101B (da) 11beta-(4-isopropenylphenyl)-oestra-4,9-diener, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende disse forbindelser samt anvendelsen af forbindelserne til fremstilling af laegemidler
EP1776378B1 (en) Process for the preparation 2-substituted-derivatives of estrone and estradiol
FI78710B (fi) Foerfarande foer framstaellning av nya 19-tio-androstanderivat och deras 4,5-dihydroanaloger.
DK167766B1 (da) 17beta-(cyclopropyloxy(thio))-androst-5-en-3beta-ol- og -4-en-3-on-forbindelser og fremgangsmaade til deres fremstilling
EP0558416B1 (fr) Nouveaux stéroides comportant en position 17 un radical méthylène lactone, leur procédé et des intermédiaires de préparation, leur application comme médicaments et les compositions pharmaceutiques les renfermant
EP3013847A1 (en) Therapeutically active estratrienthiazole derivatives as inhibitors of 17.beta.-hydroxy-steroid dehydrogenase, type 1
Nickisch et al. Aldosterone antagonists. 3. Synthesis and activities of steroidal 7. alpha.-(alkoxycarbonyl)-15, 16-methylene spirolactones
FI57263B (fi) Foerfarande foer framstaellning av nya depao-steroidestrar med hormonverkan
US4634694A (en) Novel Δ4 - and Δ5 -androstene derivatives and pharmaceutical compositions containing these derivatives
HUT56850A (en) Process for producing 14alpha, 17alpha-ethano estratriene derivatives and pharmaceutical compositions comprising same
FI58779B (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara aldosteron-antagonistiska steroidfoereningar av spiroxanserien med en syrehaltig grupp i 19-staellningen
Sondheimer et al. Steroids. LXII. 1 Synthesis of Progesterone 3-Cycloethylene Ketal

Legal Events

Date Code Title Description
PHB Application deemed withdrawn due to non-payment or other reasons